Related content

Update on the pharmacogenomics of proton pump inhibitors

By Hagymáási Krisztina   Müüllner Katalin   Herszéényi Láászlóó   Tulassay Zsolt  

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 873-888

Future Medicine

Access to resources Recommend Favorite

Update on the clinical pharmacogenomics of organ transplantation

By Burckart Gilbert J   Amur Shashi  

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 227-236

Future Medicine

Access to resources Recommend Favorite

Toward the pharmacogenomics of cystic fibrosis – an update

By Sangiuolo Federica   D’Apice Maria Rosaria   Gambardella Stefano   Di Daniele Nicola   Novelli Giuseppe  

Pharmacogenomics, Vol. 5, Iss. 7, 2004-10 ,pp. : 861-878

Future Medicine

Access to resources Recommend Favorite

Advances in pharmacogenomics technologies

By Bhasker C Ramana   Hardiman Gary  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite

Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics

By Soong Richie   Diasio Robert B  

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 835-847

Future Medicine

Access to resources Recommend Favorite